The aim of the study was to compare the circulating levels of oxLDL, CRP, and some adipokines in lean, overweight, and obese patients with T2DM, in order to analyze how these biomarkers vary with BMI and if any of them may track with insulin resistance, regardless of BMI. Here, CRP is linked to Insulin resistance.